Insufficient scRNA-seq data for expression of PRG2 at single-cell level.
Insufficient scRNA-seq data for expression of PRG2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 351.39 | 225 / 226 | 2% | 0.03 | 9 / 406 |
breast | 96% | 206.25 | 439 / 459 | 0% | 0.00 | 3 / 1118 |
adipose | 95% | 303.53 | 1145 / 1204 | 0% | 0 | 0 / 0 |
spleen | 95% | 409.78 | 228 / 241 | 0% | 0 | 0 / 0 |
lung | 88% | 208.44 | 507 / 578 | 2% | 0.03 | 19 / 1155 |
thymus | 89% | 153.57 | 583 / 653 | 0% | 0 | 0 / 605 |
peripheral blood | 85% | 4519.70 | 789 / 929 | 0% | 0 | 0 / 0 |
skin | 81% | 251.32 | 1457 / 1809 | 1% | 0.01 | 4 / 472 |
esophagus | 63% | 65.51 | 904 / 1445 | 0% | 0 | 0 / 183 |
blood vessel | 54% | 56.27 | 726 / 1335 | 0% | 0 | 0 / 0 |
uterus | 42% | 28.15 | 72 / 170 | 0% | 0 | 0 / 459 |
prostate | 42% | 30.55 | 103 / 245 | 0% | 0 | 0 / 502 |
intestine | 39% | 32.77 | 376 / 966 | 0% | 0.02 | 1 / 527 |
muscle | 34% | 33.20 | 274 / 803 | 0% | 0 | 0 / 0 |
bladder | 33% | 41.05 | 7 / 21 | 0% | 0.01 | 2 / 504 |
heart | 29% | 25.09 | 248 / 861 | 0% | 0 | 0 / 0 |
stomach | 22% | 14.87 | 80 / 359 | 0% | 0 | 0 / 286 |
ovary | 22% | 14.31 | 40 / 180 | 0% | 0 | 0 / 430 |
kidney | 19% | 15.07 | 17 / 89 | 0% | 0 | 0 / 901 |
adrenal gland | 11% | 9.60 | 28 / 258 | 0% | 0 | 0 / 230 |
pancreas | 10% | 8.77 | 33 / 328 | 1% | 0.01 | 1 / 178 |
brain | 3% | 1.81 | 75 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006955 | Biological process | immune response |
GO_0010936 | Biological process | negative regulation of macrophage cytokine production |
GO_0002215 | Biological process | defense response to nematode |
GO_0032753 | Biological process | positive regulation of interleukin-4 production |
GO_0032693 | Biological process | negative regulation of interleukin-10 production |
GO_0042742 | Biological process | defense response to bacterium |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0030133 | Cellular component | transport vesicle |
GO_0008201 | Molecular function | heparin binding |
GO_0030021 | Molecular function | extracellular matrix structural constituent conferring compression resistance |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PRG2 |
Protein name | Bone marrow proteoglycan (BMPG) (Proteoglycan 2) [Cleaved into: Eosinophil granule major basic protein (EMBP) (MBP) (Pregnancy-associated major basic protein)] |
Synonyms | MBP |
Description | FUNCTION: Cytotoxin and helminthotoxin. Also induces non-cytolytic histamine release from human basophils. Involved in antiparasitic defense mechanisms and immune hypersensitivity reactions. The proform acts as a proteinase inhibitor, reducing the activity of PAPPA. . |
Accessions | P13727 ENST00000533605.5 [P13727-2] ENST00000311862.10 [P13727-1] ENST00000525955.1 [P13727-1] |